Loading…
Attending this event?
Back To Schedule
Tuesday, June 21 • 1:45pm - 2:45pm
#243: Technology-Enabled Clinical Trials Using Electronic Health Record (EHR)-Derived Real-World Data: Opportunities and Limitations

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Component Type: Session
Level: Intermediate
CE: ACPE 1.00 Knowledge UAN: 0286-0000-22-566-L04-P ; CME 1.00; RN 1.00

This session will focus on examining how technology can be leveraged to make clinical trials more widely accessible, inclusive and efficient and how “intentionally collected data” from EHRs can be used for prospective clinical research. Join the DIA Good Clinical Practices & QA Community for a follow up round table discussion (session #256 RT) on Tuesday, June 21, 3:00pm - 4:00pm.

Learning Objectives

Identify how technology can be useful in making clinical trials more inclusive; Recognize how EHR-derived data can contribute to the design and conduct of clinical trials; Discuss the potential for prospective data to be captured at the point of care through the EHR.

Chair

Neal Meropol, DrMed

Speaker

Regulatory Perspective
Donna Rivera, PharmD, MSc

Industry Perspective
Kent Thoelke

Investigator Perspective
Stephanie L. Graff, MD, FACP



Speakers
avatar for Neal Meropol

Neal Meropol

Vice President of Research Oncology, Flatiron Health, United States
Neal J. Meropol, MD is a medical oncologist, clinical investigator and outcomes researcher who serves as Vice President of Research Oncology at Flatiron Health. In this role, he provides scientific and clinical leadership in leveraging Flatiron’s technology platforms to close the... Read More →
avatar for Stephanie Graff

Stephanie Graff

Assistant Professor, Brown University; Director of Breast Oncology Program, Lifespan Cancer Institute, United States
Dr. Stephanie Graff, MD, FACP is Director of Breast Oncology at Lifespan Cancer Institute, Legorreta Cancer Center at Brown University in Providence, Rhode Island. She serves as co-lead of Breast Cancer Translational Research Disease Working Group and Assistant Professor of Medicine... Read More →
avatar for Donna Rivera

Donna Rivera

Associate Director for Pharmacoepidemiology, OCE, FDA, United States
Donna R. Rivera, PharmD., MSc., is the Associate Director of Pharmacoepidemiology in the Oncology Center of Excellence at the US Food and Drug Administration. She leads the Oncology Real World Evidence (RWE) Program, focused on the use of Real World Data (RWD) and RWE for regulatory... Read More →
KT

Kent Thoelke

Former Chief Innovation Officer, ICON, Consultant, Ireland


Tuesday June 21, 2022 1:45pm - 2:45pm CDT
Room 176 McCormick Place 2301 South Indiana Avenue Gate 40 Chicago, IL 60616
  02: ClinTrials -ClinOps, Session |   03: Data-Tech in Clinical Trials, Session